Influx Healthtech Ratios

Influx Healthtech Ltd Ratios

The Influx Healthtech Ltd Ratios page provides a complete fundamental analysis of Influx Healthtech Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Influx Healthtech Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Influx Healthtech Ltd (NSE: INFLUX, BSE: 93847) is currently trading at ₹219.55, with a market capitalization of ₹4.97B. As a major player in the Health technology sector and Pharmaceuticals: other industry, Influx Healthtech Ltd remains a key stock for fundamental analysis using Influx Healthtech Ltd Ratios.

Influx Healthtech Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Influx Healthtech Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Influx Healthtech Ltd Ratios.

Historically, the Influx Healthtech Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

The decline in Influx Healthtech Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Influx Healthtech Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Influx Healthtech Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Influx Healthtech Ltd P/S ratio currently stands at 0, an important part of Influx Healthtech Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

A stable or declining Influx Healthtech Ltd P/S ratio indicates cautious market sentiment.

Influx Healthtech Ltd Price to Cash Flow Ratio (P/CF)

The Influx Healthtech Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Influx Healthtech Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

The declining Influx Healthtech Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Influx Healthtech Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Influx Healthtech Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Influx Healthtech Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Influx Healthtech Ltd EV/EBITDA ratio is currently 0, a key metric in Influx Healthtech Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Stable Influx Healthtech Ltd EV/EBITDA indicates balanced valuation.

Influx Healthtech Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Influx Healthtech Ltd D/E ratio is currently 0.01, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.01
• 2023: 0.01
• 2022: 0.07
• 2021: 0.14

Influx Healthtech Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Influx Healthtech Ltd ROE currently stands at 44.98%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 44.98
• 2023: 64.06
• 2022: 89.32
• 2021: 0

Influx Healthtech Ltd demonstrates strong profitability and efficient capital utilization.

Influx Healthtech Ltd Ratios Analysis Summary

The Influx Healthtech Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Influx Healthtech Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Influx Healthtech Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.